openPR Logo
Press release

Oligonucleotide-based Therapies Market Supports Growing Demand for Bioproduction

10-28-2021 03:25 PM CET | Health & Medicine

Press release from: The Insight Partners

Oligonucleotide-based Therapies Market Supports Growing

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Oligonucleotides are short chain RNA or DNA typically made by using automated synthesizers. Oligonucleotides therapy is different from conventional medicine since it can inhibit the expression of specific genes and their development takes place with the raw chemical modified artificial nucleus acids. This lead to development of brand new oligonucleotides targeting certain genes and treating chronic diseases. They are broadly used in applications such as infectious diseases, oncology, kidney diseases, and cardiovascular diseases.

The "Global Oligonucleotide-Based Therapies Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the oligonucleotide-based therapies market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading oligonucleotide-based therapies market players and offers key trends and opportunities in the market.

To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00022877/?utm_source=OpenPR&utm_medium=10291

Here we have listed the top Oligonucleotide-based Therapies Market companies

1. PCI Biotech
2. SomaGenics
3. InteRNA Technologies
4. Frontiers
5. miRagen Therapeutics, Inc.
6. Ionis Pharmaceuticals, Inc.
7. Aligos Therapeutics
8. Gilead Sciences, Inc.
9. Biogen Inc.
10. Regulus Therapeutics Inc.

Highlights the following key factors:

1) Business description-A detailed description of the company’s operations and business divisions.

2) Corporate strategy – Analyst’s summarization of the company’s business strategy.

3) SWOT Analysis-A detailed analysis of the company’s strengths, weakness, opportunities, and threats.

4) Company history – Progression of key events associated with the company.

5) Major products and services-A list of major products, services, and brands of the company.

6) Key competitors – A list of key competitors to the company.

7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

8) Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 7 years history.

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Oligonucleotide-based Therapies Market which would mention How the Covid-19 is Affecting the Oligonucleotide-based Therapies Market Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Oligonucleotide-based Therapies Market Players to fight Covid-19 Impact.

ASSESING THE COVID-19 IMPACT on Oligonucleotide-based Therapies Market ? Visit Here for PDF Copy >>https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00022877/?utm_source=OpenPR&utm_medium=10291

Segmentation

Based on type, the global oligonucleotide-based therapies market is segmented into antisense, ribozymes, aptamers, miRNA, CpG/Immunostimulatory and RNAi.
On the basis of application, the market is bifurcated into infectious diseases, oncology, neurodegenerative disorders, cardiovascular diseases, kidney diseases and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Oligonucleotide-based Therapies Market based on product and application. It also provides market size and forecast till 2027 for overall Oligonucleotide-based Therapies Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oligonucleotide-based Therapies Market - By Type
1.3.2 Oligonucleotide-based Therapies Market - By Application
1.3.3 Oligonucleotide-based Therapies Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. OLIGONUCLEOTIDE-BASED THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. OLIGONUCLEOTIDE-BASED THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/sample/TIPRE00022877/?utm_source=OpenPR&utm_medium=10291

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oligonucleotide-based Therapies Market Supports Growing Demand for Bioproduction here

News-ID: 2446619 • Views:

More Releases from The Insight Partners

Dacron Vascular Grafts Market Report: Unlocking Growth Potential and Addressing Challenges
Dacron Vascular Grafts Market Report: Unlocking Growth Potential and Addressing …
United States of America - 26 Sep 2025 The Insight Partners is proud to announce its newest market report, Dacron Vascular Grafts Market: An In-Depth Analysis of the Market. The report offers a comprehensive overview of the market, detailing the current scenario and providing growth projections for the forecast period. Overview of Dacron Vascular Grafts Market The Dacron Vascular Grafts Market has experienced considerable development, characterized by both growth and shifting dynamics.
Global Brownie Mix Market Outlook: 5.9% CAGR Forecast Through 2031
Global Brownie Mix Market Outlook: 5.9% CAGR Forecast Through 2031
The Brownie Mix market is set to grow steadily in the years ahead, fueled by changing consumer preferences, convenient baking practices, and innovation in products. As per the most recent estimates, the market will expand at a 5.9 % CAGR from 2025 through 2031. Major players such as ADM, Bob's Red Mill Natural Foods, Chelsea Milling Co, Dawn Food Products, Inc., General Mills, Ghirardelli Chocolate Company, Pamela's Products, Really Great
A Complete Study Guide to Refrigeration Coolers
A Complete Study Guide to Refrigeration Coolers
The Refrigeration Coolers Market is expected to register a CAGR of 6.4% from 2025 to 2031, with a market size expanding from US$ 4.50 billion in 2024 to US$ 7.48 billion by 2031. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00039596?utm_source=OpenPr&utm_medium=10457 Refrigeration Coolers Market Segmentation: Offering- Condensers Compressors Evaporators Air Cooler Mobility- Stationary Portable Refrigerant Type- Ammonia Carbon Dioxide HFC/HFO Propane Glycol Brine Hydrocarbon Blends Market leaders and key company profiles: Western Refrigeration Pvt Ltd Rockwell Bluestar Carrier Symphony Limited Danfoss BlueCold Refrigeration Greencooler Refcon Secop Contact Us: If you have any queries about this report or if you would like further information,
Top Drug Development Companies Regional and Data Analysis to 2031
Top Drug Development Companies Regional and Data Analysis to 2031
Drug development is the process of bringing a new pharmaceutical drug from discovery to market. It involves several stages: identifying potential compounds, preclinical testing in labs and animals, and multiple phases of clinical trials in humans to ensure safety and effectiveness. Regulatory approval is then sought before the drug can be marketed. This process is lengthy, costly, and highly regulated to protect patient health. Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00024322/?utm_source=OpenPR&utm_medium=10826 The List of

All 5 Releases


More Releases for Therapies

GM1 Gangliosidosis Market: Epidemiology, Therapies, Companies, DelveInsight | Pa …
GM1 Gangliosidosis therapies, such as PBGM01, and others, are expected to boost the GM1 Gangliosidosis Market in the upcoming years. DelveInsight has launched a new report on "GM1 Gangliosidosis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the GM1 Gangliosidosis, historical and forecasted epidemiology as well as the GM1 Gangliosidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover
Facioscapulohumeral Muscular Dystrophy Pipeline Assessment 2024: Therapies, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Facioscapulohumeral Muscular Dystrophy pipeline constitutes 10+ key companies continuously working towards developing 10+ Facioscapulohumeral Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Facioscapulohumeral Muscular Dystrophy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Facioscapulohumeral Muscular
Intratumoral Cancer Therapies Market Report 2024 - Intratumoral Cancer Therapies …
"The Business Research Company recently released a comprehensive report on the Global Intratumoral Cancer Therapies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The intratumoral cancer therapies
Innovative Therapies in Alcohol Rehabilitation
Alcohol rehabilitation has evolved significantly over the years, with innovative therapies emerging as crucial elements in the journey to recovery. These groundbreaking approaches go beyond traditional methods, providing individuals struggling with alcohol addiction with a diverse set of tools to achieve and maintain sobriety. In this article, we delve into innovative therapies, exploring their effectiveness and impact on alcohol rehabilitation if you'd like to know more about alcohol rehab in
B-cell Maturation Antigen (BCMA) Targeted Therapies Market New Development of No …
A global prevalence of over one million cases. B-cell maturation antigen (BCMA), is a cell surface protein that is expressed on the malignant plasma cells. This cell surface protein has emerged as a very selective antigen targeted therapy for the treatment of multiple myeloma. BCMA targeted therapies actively involve three major types of immunotherapies on the basis of product class namely, chimeric antigen receptor T-cells (CAR T Cells), bispecific antibodies,
Viral Vector Contract Manufacturing Market Outlook 2021- Gene Therapies, Cell Th …
The latest report released on Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines Market analyses areas where there is still room for improvement. Irrespective of industry, organization size or geographic location, the Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines Market study suggests that advanced technologies are playing a bigger role than ever before. The assessment provides trend,